agreed Gavin, with the significant risk of cell breakdown over time with potential cancerous cells forming this tech will need 25+ years of phase 3 data before FDA would think of approving.
and a few billion in funding and massive dilution, however that is based on credibility and capability of the CYP team…which is frankly Zero so this thing is going to die in a ditch very soon.
IMO DYOR
CYP Price at posting:
31.0¢ Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)